Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Increases By 715.4%
Short Interest in PURE Bioscience, Inc. (OTCMKTS:PURE) Increases By 715.4%
PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) was the recipient of a large growth in short interest in January. As of January 31st, there was short interest totalling 10,600 shares, a growth of 715.4% from the January 15th total of 1,300 shares. Based on an average daily trading volume, of 34,100 shares, the days-to-cover ratio is presently 0.3 days.
純生物科學, 公司. (OTCMKTS: 純 — 獲得評級) 是一月份短期利益大增長的收件人.截至 1 月 31 日，短期利息共達 10,600 股，較 1 月 15 日的 1,300 股股份增長了 715.4%。以 34,100 股的平均每日交易量計算，日數佔覆蓋率目前為 0.3 天。
PURE Bioscience Stock Performance
純生物科技股票表現
PURE Bioscience stock remained flat at $0.12 during midday trading on Friday. 6,412 shares of the company were exchanged, compared to its average volume of 27,970. PURE Bioscience has a 12 month low of $0.07 and a 12 month high of $0.24. The company has a market capitalization of $13.36 million, a price-to-earnings ratio of -3.00 and a beta of 0.25. The stock has a 50-day simple moving average of $0.11 and a two-hundred day simple moving average of $0.17.
PURE 生物科技股票在周五中午交易期間保持平穩 0.12 美元。該公司的 6,412 股股份被交換，而其平均交易量為 27,970。純生物科學有一個 12 個月的低點 0.07 美元和 12 個月的高點 0.24 美元。該公司的市值為 1336 萬美元，價格與收益比為 -3.00，測試版為 0.25。該股票的 50 天簡單移動平均線為 0.11 美元，兩百日簡單移動平均線為 0.17 美元。
PURE Bioscience (OTCMKTS:PURE – Get Rating) last posted its quarterly earnings data on Wednesday, December 14th. The company reported ($0.01) earnings per share for the quarter. PURE Bioscience had a negative return on equity of 135.85% and a negative net margin of 206.26%. The firm had revenue of $0.47 million during the quarter.
純生物科學（OTCMKTS：純 — 獲得評分）上次發布了其季度收益數據，週三，12 月 14 日。該公司報告了本季度每股盈利（0.01 美元）。PURE 生物科技的負資產回報率為 135.85%，負淨利潤率為 206.26%。該公司在本季度的收入為 0.47 萬美元。
Hedge Funds Weigh In On PURE Bioscience
對沖基金權衡 PURE 生物科學
PURE Bioscience Company Profile
PURE 生物科技公司簡介
(Get Rating)
(取得評分)
PURE Bioscience, Inc engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.
PURE 生物科技股份有限公司致力於發現、開發和商業化專利抗菌產品，用於病原體和衛生控制。它提供基於檸檬酸銀二氫的消毒和消毒產品。該公司由邁克爾 ·L· 克勞爾於 1992 年 8 月 24 日成立，總部位於加利福尼亞州庫卡蒙格牧場。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
- Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
- The Bottom Is In For Cloudflare Stock
- 3 Tickers Leading a Meme Stock Revival
- Microsoft-Activision Blizzard Merger: Navigating Risk and Reward
- Wall Street Says These 3 Stocks Will Grow Earnings In 2023
- 免費獲取有關純生物科學（PURE）的研究報告
- 雪花會有艱難的雪橇，試圖保持拉力賽活著嗎？
- 底部是雲耀斑股票
- 3 個帶領模因股票復興的行情
- 微軟動視暴雪合併：導航風險與回報
- 華爾街稱這 3 隻股票將在 2023 年增長盈利
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收 PURE 生物科學日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 PURE Bioscience 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。